Sodium Hexametaphosphate from China
Total Page:16
File Type:pdf, Size:1020Kb
CONTENTS Page Determination ................................................................................................................................. 1 Views of the Commission ............................................................................................................... 3 Information obtained in this review ..................................................................................... I-1 Background ................................................................................................................................ I-1 Responses to the Commission’s Notice of Institution .............................................................. I-1 Individual responses .............................................................................................................. I-1 Party comments on adequacy ............................................................................................... I-2 The original investigation and subsequent reviews .................................................................. I-3 The original investigation ...................................................................................................... I-3 The first five-year review ....................................................................................................... I-3 Previous and related investigations .......................................................................................... I-3 Actions at Commerce ................................................................................................................ I-4 Commerce’s administrative reviews ..................................................................................... I-4 The product ............................................................................................................................... I-5 Commerce’s scope ................................................................................................................ I-5 U.S. tariff treatment .............................................................................................................. I-5 Description and uses ............................................................................................................. I-6 Manufacturing process ........................................................................................................ I-11 The industry in the United States ........................................................................................... I-12 U.S. producers ..................................................................................................................... I-12 Recent developments .......................................................................................................... I-13 U.S. producers’ trade and financial data ............................................................................. I-13 Definitions of the domestic like product and domestic industry ........................................... I-14 U.S. imports and apparent U.S. consumption......................................................................... I-15 U.S. importers ...................................................................................................................... I-15 U.S. imports ......................................................................................................................... I-15 Apparent U.S. consumption and market shares ................................................................. I-21 i CONTENTS Page The industry in China ............................................................................................................... I-22 Capacity and production ..................................................................................................... I-23 Exports, imports and net trade balance .............................................................................. I-24 Antidumping or countervailing duty orders in third-country markets ................................... I-26 The global market ................................................................................................................... I-27 Appendixes A. Federal Register notices .................................................................................................. A-1 B. Company-specific data .................................................................................................... B-1 C. Summary data compiled in prior proceedings ................................................................ C-1 D. Purchaser questionnaire responses ................................................................................ D-1 Note.—Information that would reveal confidential operations of individual concerns may not be published. Such information is identified by brackets or by parallel lines in confidential reports and is deleted and replaced with asterisks in public reports. ii UNITED STATES INTERNATIONAL TRADE COMMISSION Investigation No. 731-TA-1110 (Second Review) Sodium Hexametaphosphate from China DETERMINATION On the basis of the record1 developed in the subject five-year review, the United States International Trade Commission (“Commission”) determines, pursuant to the Tariff Act of 1930 (“the Act”), that revocation of the antidumping duty order on sodium hexametaphosphate from China would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time.2 BACKGROUND The Commission, pursuant to section 751(c) of the Act (19 U.S.C. 1675(c)), instituted this review on June 1, 2018 (83 F.R. 25488) and determined on September 4, 2018 that it would conduct an expedited review (83 F.R. 50958, October 10, 2018). 1 The record is defined in sec. 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR 207.2(f)). 2 Commissioner Meredith M. Broadbent did not participate in the vote. Views of the Commission Based on the record in this second five-year review, we determine under section 751(c) of the Tariff Act of 1930, as amended (“the Tariff Act”), that revocation of the antidumping duty order on sodium hexametaphosphate from China would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time.1 Background A. The Original Investigation On February 8, 2007, ICL Specialty Products Inc. (“ICL”) and Innophos, Inc. (“Innophos”), domestic producers of sodium hexametaphosphate (“SHMP”) (collectively, “domestic interested parties” or “domestic producers”), filed an antidumping duty petition on imports of SHMP from China. In March 2008, the Commission found a domestic industry was materially injured by reason of less-than-fair-value (“LTFV”) imports of SHMP from China.2 Consequently, on March 19, 2008, Commerce issued an antidumping duty order.3 B. The First Review On February 1, 2013, the Commission instituted its first five-year review of the antidumping duty order on SHMP from China.4 In June 2013, the Commission reached an affirmative determination after conducting an expedited review.5 As a result, effective July 17, 2013, Commerce issued a continuation of the antidumping duty order.6 1 Commissioner Broadbent did not participate in this review. 2 Sodium Hexametaphosphate from China, Inv. No. 731-TA-1110 (Final), USITC Pub. 3984 at 1 (Mar. 2008) (“Original Determination”). 3 Notice of Antidumping Duty Order: Sodium Hexametaphosphate from the People’s Republic of China, 73 Fed. Reg. 14772 (Mar. 19, 2008). 4 Sodium Hexametaphosphate from China: Institution of a Five-Year Review Concerning the Antidumping Duty Order on Sodium Hexametaphosphate from China, 78 Fed. Reg. 7452 (Feb. 1, 2013). 5 Sodium Hexametaphosphate from China, Inv. No. 731-TA-1110 (Review), USITC Pub. 4410 at 3 (June 2013) (“First Review”). 6 Sodium Hexametaphosphate from the People’s Republic of China: Continuation of Antidumping Duty Order, 78 Fed. Reg. 42754 (July 17, 2013). 3 C. The Current Review On June 1, 2018, the Commission instituted the instant five-year review.7 On July 2, 2018, the domestic interested parties jointly filed a response to the notice of institution.8 On September 4, 2018, the Commission determined that the domestic interested party group response to its notice of institution was adequate;9 the Commission did not receive a response from any respondent interested party and determined that the respondent interested party group response to the notice of institution was inadequate.10 The Commission did not find any circumstances that would warrant conducting a full review and determined that it would conduct an expedited review pursuant to section 751(c)(3) of the Tariff Act.11 On October 10, 2018, the domestic interested parties filed comments with the Commission pursuant to Commission rule 207.62(d).12 U.S. industry data are based on trade and financial data submitted by the domestic interested parties in the original investigation, the first five-year review, and this current five- year review in response to the notice of institution.13 The domestic interested parties estimate that they accounted for *** percent of domestic production of SHMP in 2017.14 U.S. import and foreign industry data and related information are based on information from the original investigation and prior review, available information submitted by the domestic interested parties in this expedited review, official import statistics of the Department of Commerce (“Commerce”), and publicly